Annual report pursuant to Section 13 and 15(d)

Statements of Changes in Shareholders' Equity (Deficit)

v3.20.1
Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
(Accumulated Deficit) Retained Earnings [Member]
Total
Balance at Dec. 31, 2017 $ 287 $ 24,713 $ (14,225) $ 10,775
Balance, shares at Dec. 31, 2017 [1] 2,875,000      
Net income (loss) (14,772) (14,772)
Balance at Dec. 31, 2018 $ 287 24,713 (28,997) (3,997)
Balance, shares at Dec. 31, 2018 [1] 2,875,000      
Sale of 10,800,000 Units, net of underwriting discounts $ 1,080 104,794,469 104,795,549
Sale of 10,800,000 Units, net of underwriting discounts, shares [1] 10,800,000      
Sale of 395,000 Private Units $ 40 3,949,960 3,950,000
Sale of 395,000 Private Units, shares [1] 395,000      
Forfeiture of Founder Shares $ (17) 17
Forfeiture of Founder Shares, shares [1] (175,000)      
Ordinary shares subject to possible redemption $ (1,035) (105,502,956) (105,503,991)
Ordinary shares subject to possible redemption, shares [1] (10,344,550)      
Net income (loss) 1,762,447 1,762,447
Balance at Dec. 31, 2019 $ 355 $ 3,266,203 $ 1,733,450 $ 5,000,008
Balance, shares at Dec. 31, 2019 [1] 3,550,450      
[1] As of December 31, 2018, this amount included an aggregate of 375,000 shares that were subject to forfeiture to the extent that the underwriters' over-allotment option was not exercised in full. As a result of the underwriters' election to partially exercise their over-allotment option in January 2019, an aggregate of 200,000 shares were no longer subject to forfeiture and 175,000 shares were subject to forfeiture to the extent that the underwriters' over-allotment was not exercised in full. The remaining over-allotment option expired unexercised on March 17, 2019 (see Note 7).